BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amin M, Lockhart AC. The potential role of immunotherapy to treat colorectal cancer. Expert Opin Investig Drugs. 2015;24:329-344. [PMID: 25519074 DOI: 10.1517/13543784.2015.985376] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu L, Li H, Xu Q, Wu Y, Chen D, Yu F. Antitumor activity of recombinant oncolytic vaccinia virus with human IL2. Open Med (Wars) 2022;17:1084-91. [PMID: 35799600 DOI: 10.1515/med-2022-0496] [Reference Citation Analysis]
2 Pecci F, Cantini L, Bittoni A, Lenci E, Lupi A, Crocetti S, Giglio E, Giampieri R, Berardi R. Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer. Curr Treat Options Oncol 2021;22:69. [PMID: 34110510 DOI: 10.1007/s11864-021-00870-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ji L, Shen W, Zhang F, Qian J, Jiang J, Weng L, Tan J, Li L, Chen Y, Cheng H, Sun D. Worenine reverses the Warburg effect and inhibits colon cancer cell growth by negatively regulating HIF-1α. Cell Mol Biol Lett 2021;26:19. [PMID: 34006215 DOI: 10.1186/s11658-021-00263-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhao Q, Guo J, Zhao Y, Shen J, Kaboli PJ, Xiang S, Du F, Wu X, Li M, Wan L, Li X, Wen Q, Li J, Zou C, Xiao Z. Comprehensive assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers. Epigenomics 2020;12:2155-71. [PMID: 33337915 DOI: 10.2217/epi-2020-0093] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Zhao X, Qi X, Lian W, Tong X, Wang H, Su L, Wei P, Zhuang Z, Gong J, Bai L. Trichomicin Suppresses Colorectal Cancer via Comprehensive Regulation of IL-6 and TNFα in Tumor Cells, TAMs, and CAFs. Front Pharmacol 2020;11:386. [PMID: 32317968 DOI: 10.3389/fphar.2020.00386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zhang Y, Diao N, Lee CK, Chu HW, Bai L, Li L. Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses. Mol Ther 2020;28:89-99. [PMID: 31607540 DOI: 10.1016/j.ymthe.2019.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
7 Matos AI, Carreira B, Peres C, Moura LI, Conniot J, Fourniols T, Scomparin A, Martínez-barriocanal Á, Arango D, Conde JP, Préat V, Satchi-fainaro R, Florindo HF. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 2019;307:108-38. [DOI: 10.1016/j.jconrel.2019.06.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
8 Sun Y, Wang S, Yang H, Wu J, Li S, Qiao G, Wang S, Wang X, Zhou X, Osada T, Hobeika A, Morse MA, Ren J, Lyerly HK. Impact of synchronized anti-PD-1 with Ad-CEA vaccination on inhibition of colon cancer growth. Immunotherapy 2019;11:953-66. [PMID: 31192764 DOI: 10.2217/imt-2019-0055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Martinez-Ciarpaglini C, Oltra S, Roselló S, Roda D, Mongort C, Carrasco F, Gonzalez J, Santonja F, Tarazona N, Huerta M, Espí A, Ribas G, Ferrández A, Navarro S, Cervantes A. Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression. Mod Pathol 2019;32:306-13. [PMID: 30206410 DOI: 10.1038/s41379-018-0124-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
10 Li Y, Chen M, Liu J, Li L, Yang X, Zhao J, Wu M, Ye M. Upregulation of MicroRNA 18b Contributes to the Development of Colorectal Cancer by Inhibiting CDKN2B. Mol Cell Biol 2017;37:e00391-17. [PMID: 28784723 DOI: 10.1128/MCB.00391-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
11 Rangel-Sosa MM, Aguilar-Córdova E, Rojas-Martínez A. Immunotherapy and gene therapy as novel treatments for cancer. Colomb Med (Cali) 2017;48:138-47. [PMID: 29213157 DOI: 10.25100/cm.v48i3.2997] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
12 Correale P, Botta C, Ciliberto D, Pastina P, Ingargiola R, Zappavigna S, Tassone P, Pirtoli L, Caraglia M, Tagliaferri P. Immunotherapy of colorectal cancer: new perspectives after a long path. Immunotherapy 2016;8:1281-92. [PMID: 27993089 DOI: 10.2217/imt-2016-0089] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
13 Yin L, Zhao C, Han J, Li Z, Zhen Y, Xiao R, Xu Z, Sun Y. Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo. Ther Clin Risk Manag 2017;13:117-30. [PMID: 28223815 DOI: 10.2147/TCRM.S128575] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
14 Li H, Zhang P. Role of intestinal microecology in precision treatment of colorectal cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(32): 4354-4361 [DOI: 10.11569/wcjd.v24.i32.4354] [Reference Citation Analysis]
15 Taylor ES, McCall JL, Girardin A, Munro FM, Black MA, Kemp RA. Functional impairment of infiltrating T cells in human colorectal cancer. Oncoimmunology. 2016;5:e1234573. [PMID: 27999752 DOI: 10.1080/2162402x.2016.1234573] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
16 Zhou L, Lu L, Wicha MS, Chang AE, Xia JC, Ren X, Li Q. Promise of cancer stem cell vaccine. Hum Vaccin Immunother 2015;11:2796-9. [PMID: 26337078 DOI: 10.1080/21645515.2015.1083661] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Li X, Nie J, Mei Q, Han WD. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma. World J Gastroenterol 2016; 22(23): 5317-5331 [PMID: 27340348 DOI: 10.3748/wjg.v22.i23.5317] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
18 Jacobs J, Smits E, Lardon F, Pauwels P, Deschoolmeester V. Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. J Immunol Res 2015;2015:158038. [PMID: 26605342 DOI: 10.1155/2015/158038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]